WEBULL
News
CDNA
19.81
+3.50%
0.67
Weekly Report: what happened at CDNA last week (1229-0102)?
Weekly Report · 1d ago
Weekly Report: what happened at CDNA last week (1222-1226)?
Weekly Report · 12/29/2025 09:19
CareDx Awards Inducement RSUs to 39 New Employees Under 2025 Equity Plan
Reuters · 12/26/2025 21:05
CAREDX ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 12/26/2025 21:05
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Barchart · 12/26/2025 15:05
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade)
Seeking Alpha · 12/22/2025 15:15
Weekly Report: what happened at CDNA last week (1215-1219)?
Weekly Report · 12/22/2025 09:19
CareDx Wins Preliminary Court Approval for Derivative Settlement
TipRanks · 12/18/2025 22:34
CAREDX INC: SHALL ENGAGE OUTSIDE COUNSEL BY NO LATER THAN END OF Q1 OF 2026
Reuters · 12/18/2025 22:00
CareDx Provides Notice of Proposed Derivative Settlement
Barchart · 12/18/2025 16:00
CareDx Adopts Majority Vote Standard for Director Elections
Reuters · 12/15/2025 21:02
CareDx Is Maintained at Equal-Weight by Wells Fargo
Dow Jones · 12/15/2025 18:28
Wells Fargo Maintains Equal-Weight on CareDx, Raises Price Target to $18
Benzinga · 12/15/2025 18:18
CareDx price target raised to $18 from $14 at Wells Fargo
TipRanks · 12/15/2025 11:32
Weekly Report: what happened at CDNA last week (1208-1212)?
Weekly Report · 12/15/2025 09:20
U.S. RESEARCH ROUNDUP-Applied Materials, Coca-Cola, Glacier Bancorp
Reuters · 12/15/2025 08:11
Weekly Report: what happened at CDNA last week (1201-1205)?
Weekly Report · 12/08/2025 09:20
CareDx Inc. Secretary and General Counsel Jeffrey Adam Novack Reports Sale of Common Shares
Reuters · 12/05/2025 21:08
Weekly Report: what happened at CDNA last week (1124-1128)?
Weekly Report · 12/01/2025 09:19
More
Webull provides a variety of real-time CDNA stock news. You can receive the latest news about Caredx through multiple platforms. This information may help you make smarter investment decisions.
About CDNA
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.